{"organizations": [], "uuid": "f715fcc1b4e59bc97324d17ceb6408317f9944d1", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180208.html", "section_title": "Archive News &amp; Video for Thursday, 08 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-indias-glenmark-pharmaceuticals-de/brief-indias-glenmark-pharmaceuticals-dec-qtr-consol-profit-falls-78-pct-idUSFWN1PY0J4", "country": "US", "domain_rank": 408, "title": "BRIEF-India's Glenmark Pharmaceuticals Dec-Qtr Consol Profit Falls 78 Pct", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.003, "site_type": "news", "published": "2018-02-08T18:32:00.000+02:00", "replies_count": 0, "uuid": "f715fcc1b4e59bc97324d17ceb6408317f9944d1"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-indias-glenmark-pharmaceuticals-de/brief-indias-glenmark-pharmaceuticals-dec-qtr-consol-profit-falls-78-pct-idUSFWN1PY0J4", "ord_in_thread": 0, "title": "BRIEF-India's Glenmark Pharmaceuticals Dec-Qtr Consol Profit Falls 78 Pct", "locations": [], "entities": {"persons": [], "locations": [{"name": "us", "sentiment": "none"}], "organizations": [{"name": "glenmark pharmaceuticals dec-qtr consol profit falls", "sentiment": "negative"}, {"name": "brief-india", "sentiment": "negative"}, {"name": "reuters) - glenmark pharmaceuticals ltd", "sentiment": "neutral"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 8 (Reuters) - Glenmark Pharmaceuticals Ltd:\n* DEC QUARTER CONSOL PROFIT 1.05 BILLION RUPEES VERSUS PROFIT OF 4.77 BILLION RUPEES LAST YEAR\n* CONSENSUS FORECAST FOR DEC QUARTER CONSOL PROFIT WAS 2.34 BILLION RUPEES\n* DEC QUARTER CONSOL REVENUE FROM OPERATIONS 22.04 BILLION RUPEES VERSUS 25.35 BILLION RUPEES LAST YEAR\n* SAYS US BUSINESS DEGREW BY 40.21 PERCENT TO 73.59 BILLION RUPEES DURING Q3 Source text: bit.ly/2nOGwQS Further company coverage:\n ", "external_links": ["http://bit.ly/2nOGwQS", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-08T18:32:00.000+02:00", "crawled": "2018-02-09T16:54:55.013+02:00", "highlightTitle": ""}